Q32's17 Sep 2020 22:41
It would appear we are well covered with the big labs, what's that I hear from the back of the room "what about the remote places"
I quote from today's Rns
The Company has also been investing in its rapid testing instrumentation platforms, q16 and q32, which allow for efficient and high-performance testing in near-patient environments. By the end of the year, Novacyt expects to manufacture and install an increasing number of instruments and will have capacity for significantly more as demand builds. As part of its investment, the Company is further improving the operational workflow of its reagents with these instrument platforms, reducing cycle times significantly below 60 minutes and reducing the level of operator involvement.
What a bloomin company.